Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Recruiting · NCT06997198 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities | Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, developmental disability, drug-induced dyskinesia, intellectual disability, movement disorder, nervous system disorder, neurodevelopmental disorder, psychiatric disorder, tardive dyskinesia | Recruiting | Phase 4 | 2026-07-06 | NCT06997198 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Teva Pharmaceuticals USA | 6 |
| University Hospitals Cleveland Medical Center | 62 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospitals of Cleveland | Cleveland | United States | 17 |